Patients And Methods

Patients were included by clinical records between 1998 and 2002 at our division. All patients met with international criteria of BD. Lupus anticoagulant (LA) assay was performed by Russell's viper venom time (dRVVT) and dilute APTT (dAPTT). Anticardiolipin antibodies (aCl-beta2-GP I) were assayed with specific EIA for beta2-glycoprotein I (Yamasa kit, Tokyo, Japan). "Vascular involvement" included deep venous thrombosis, subcutaneous thrombophlebitis, arteritis, and various types of venous occlusion (Table 1).

Table I. Background of BP with or without vascular involvement

with vascular

without vascular

significance

involvement

involvement

(n=15)

(n=49)

p value

Sex

male

80.0% (12)

38.8% (19)

NS

female

20.0% (3)

61.2% (30)

NS

Age, years

52.5±22.5

44.6±30.6

NS

Complications

venous arterial

73,3% (11) 26.7% (4)

Major symptoms

oral aphthae

100.0% (15)

100% (49)

NS

ocular symptom

13.3% (2)

65.3% (32)

p <0.01

cutaneous lesions

100,0% (15)

77.6% (38)

NS

genital ulcer

73.3% {11)

75.4% (37)

NS

arthritis

46.7% (7)

53.0% (26)

NS

Was this article helpful?

0 0

Post a comment